iScience Interventional
Pioneering microcatheter and imaging solutions to empower ophthalmologists in administering targeted ocular treatments with precision.
Pioneering microcatheter and imaging solutions to empower ophthalmologists in administering targeted ocular treatments with precision.
is a pioneer in developing microcatheter and imaging technologies for precise and targeted ocular treatments. Founded in 1999, the company operates in the Biotechnology and Health Care industries. Its innovative approach, known as Interventional Ophthalmology, involves microcatheter-based treatments to reach various anatomical structures within the eye. This enables the aspiration of ocular fluids or the delivery of sterile ophthalmic solutions. The company's last investment of $5.00M in debt financing occurred on 08 May 2012, with Square 1 Bank acting as the investor. With its focus on cutting-edge ophthalmic interventions, iScience Interventional holds promise for both investors and the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $5.00M | 1 |
|
08 May 2012 |
| Venture Round | $2.76M | 6 |
|
27 Jan 2012 |
| Venture Round | $3.00M | - | 18 Aug 2011 | |
| Debt Financing | $5.34M | - | 17 May 2011 | |
| Venture Round | $5.09M | - | 11 Aug 2010 |
No recent news or press coverage available for iScience Interventional.
We care about your data, and we'd love to use cookies make your experience better.
